Kloxxado® is part of our commitment to addressing the opioid epidemic through our Hikma Community Health™ initiative. Our partners include Harm Reduction Programs, Addiction Centers, Community Organizers, Music Festival Safety Groups, School Opioid Education Programs, Downtown Safety Programs. We partner on both naloxone and educational programs. Read on to learn more about why our partners chose Kloxxado®, one of the many forms of naloxone we offer.
78% of opioid overdose reversals use at least 8 mg of naloxone4
Fight Fentanyl in Your Community with Kloxxado®
- 2x more naloxone per device as Narcan® (naloxone HCl) Nasal Spray 4 mg2,4
- 2x medicine per box than Narcan®2,4
- Effective counter to fentanyl overdose2
- Community pricing and bulk orders available
Why higher-dose naloxone?
Based on real-world experiences, this short video explains why 4mg naloxone nasal spray is often not enough to reverse an opioid overdose.4
References
- KLOXXADO® (naloxone HCl) Nasal Spray [prescribing information]. Columbus, OH: Hikma Specialty USA Inc., 2021
- NARCAN® (naloxone HCl) Nasal Spray [prescribing information]. Plymouth Meeting, PA: Emergent BioSolutions Inc., 2020
- Naloxone HCl Nasal Spray [prescribing information]. Columbus, OH: Hikma Pharmaceuticals USA Inc.
- Abdelal et al., 2022, “Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders,” Harm Reduction Journal, 19:49
- FDA 2019, “Having Naloxone on Hand Can Save a Life During an Opioid Overdose,” https://www.fda.gov/consumers/consumer-updates/having-naloxone-hand-can-save-life-during-opioid-overdose
- NIDA 2021, “Naloxone DrugFacts,” National Institute on Drug Abuse, https://www.drugabuse.gov/publications/drugfacts/naloxone. Accessed Nov. 17, 2022.